These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7746716)

  • 41. Task force tackles drug-resistant pathogens.
    Traynor K
    Am J Health Syst Pharm; 2003 Aug; 60(15):1516, 1520, 1522. PubMed ID: 12951751
    [No Abstract]   [Full Text] [Related]  

  • 42. Antibiotic resistance. The big picture.
    Mazel D; Davies J
    Adv Exp Med Biol; 1998; 456():1-6. PubMed ID: 10549360
    [No Abstract]   [Full Text] [Related]  

  • 43. Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
    Pienaar E; Linderman JJ; Kirschner DE
    PLoS One; 2018; 13(5):e0196322. PubMed ID: 29746491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotics that resist resistance.
    Service RF
    Science; 1995 Nov; 270(5237):724-7. PubMed ID: 7481757
    [No Abstract]   [Full Text] [Related]  

  • 45. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibiotic tolerance among clinical isolates of bacteria.
    Handwerger S; Tomasz A
    Annu Rev Pharmacol Toxicol; 1985; 25():349-80. PubMed ID: 3890707
    [No Abstract]   [Full Text] [Related]  

  • 48. [Future of antibiotic therapy in various fields of medicine. 3. Gynecology and obstetric].
    Takase Z
    Nihon Rinsho; 1984 Mar; 42(3):587-97. PubMed ID: 6471452
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevalence of plasmid-mediated multidrug resistance determinants in fluoroquinolone-resistant bacteria isolated from sewage and surface water.
    Osińska A; Harnisz M; Korzeniewska E
    Environ Sci Pollut Res Int; 2016 Jun; 23(11):10818-10831. PubMed ID: 26893181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bacteria outwit us].
    Ajanki T
    Vardfacket; 1998 Jan; 22(1):32-4. PubMed ID: 9528635
    [No Abstract]   [Full Text] [Related]  

  • 51. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

  • 52. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 53. The burden of drug-resistant tuberculosis and mechanisms for its control.
    Raviglione MC; Gupta R; Dye CM; Espinal MA
    Ann N Y Acad Sci; 2001 Dec; 953():88-97. PubMed ID: 11795426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overcoming antimicrobial resistance by targeting resistance mechanisms.
    Poole K
    J Pharm Pharmacol; 2001 Mar; 53(3):283-94. PubMed ID: 11291743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [An experimental study on the antituberculous activity of tuberactiomycin-N].
    Toyoara M
    Kekkaku; 1972 Jun; 47(6):181-7. PubMed ID: 4628191
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of veterinary therapeutics in bacterial resistance development: animal and public health perspectives.
    Apley MD; Brown SA; Fedorka-Cray PJ; Ferenc S; House JK; Riviere JE; Rice LB; Thornsberry C; Waddell J
    J Am Vet Med Assoc; 1998 Apr; 212(8):1209-13. PubMed ID: 9569153
    [No Abstract]   [Full Text] [Related]  

  • 57. [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
    Valencia ME; Moreno V; Laguna F; González-Lahoz JM
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):37-9. PubMed ID: 11256251
    [No Abstract]   [Full Text] [Related]  

  • 58. Chemotherapy for tuberculosis.
    Seth V
    Indian Pediatr; 1996 Feb; 33(2):146-8. PubMed ID: 8772940
    [No Abstract]   [Full Text] [Related]  

  • 59. Tuberculosis drug resistance comes full circle.
    Reichman LB
    Lancet; 2008 Mar; 371(9618):1052-3. PubMed ID: 18374825
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of critical antibiotic resistance genes through routine microbiome surveillance.
    Burcham ZM; Schmidt CJ; Pechal JL; Brooks CP; Rosch JW; Benbow ME; Jordan HR
    PLoS One; 2019; 14(3):e0213280. PubMed ID: 30870464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.